ARTICLE | Company News
Clinuvel seeks Scenesse approval in EU
February 7, 2012 1:11 AM UTC
Clinuvel Pharmaceuticals Ltd. (ASX:CUV; Xetra:UR9) submitted an MAA to EMA for Scenesse afamelanotide for prophylactic treatment of erythropoietic protoporphyria (EPP). The product is a sustained-rele...